Penserra Capital Management LLC Avrobio, Inc. Transaction History

Penserra Capital Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 15, 2022	SELL	$3.45 - $6.05 $3,432 - $6,019	-995 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$5.53 - $9.28 $248 - $417	45 Added 4.74%	995 $5,000
Q2 2021 Aug 12, 2021	BUY	$7.84 - $12.6 $117 - $189	15 Added 1.6%	950 $8,000
Q1 2021 May 13, 2021	SELL	$10.54 - $19.3 $158 - $289	-15 Reduced 1.58%	935 $11,000
Q4 2020 Feb 12, 2021	BUY	$12.79 - $17.1 $8,185 - $10,944	640 Added 206.45%	950 $13,000
Q3 2020 Nov 13, 2020	BUY	$12.99 - $19.41 $4,026 - $6,017	310 New	310 $4,000

559K

Ticker AVRO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,773,900
Description
AVROBIO, Inc., a clinical-stage gene therapy company, develops ex vivo lentiviral-based gene therapies to treat rare diseases following a single dose worldwide. Its gene therapies employ hematopoietic stem cells that are collected from patients and modified with a lentiviral vector to insert functional copies of the gene that is defective in the...

Get notified when there are updates to the investment portfolio of Penserra Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Penserra Capital Management LLC with notifications on news.